Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?

JM Berthelot, L Drouet, F Lioté - Emerging microbes & infections, 2020 - Taylor & Francis
… the STING pathway in severe COVID-19, at least in patients … in some young patients with
COVID-19 [Citation20], since … poor prognosis thrombotic coagulopathy of COVID-19 to thrombo-…

Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy—either, neither, or both

M Levi, J Thachil - Seminars in Thrombosis and Hemostasis, 2020 - thieme-connect.com
… the coagulopathy.[3] It has also been suggested that undiagnosed pulmonary embolism
contributes … oxygen exchange that is sometimes seen in patients with COVID-19 infections.[4] [5] …

[HTML][HTML] COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy

MM Daughety, A Morgan, E Frost, C Kao… - Thrombosis …, 2020 - ncbi.nlm.nih.gov
… patients with COVID-19. We identified 192 consecutive patients with COVID-19 admitted …
and our initial experience with the COVID-19 population. Patients considered for escalated-…

[HTML][HTML] Coagulation and anticoagulation in COVID-19

T Hadid, Z Kafri, A Al-Katib - Blood Reviews, 2021 - Elsevier
… We propose a scoring system for COVID-19-coagulopathy (CIC Scoring) and stratification of
… ) and macrovascular thrombosis can occur in patients with severe COVID-19, which lead to …

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia

JL Vincent, M Levi, BJ Hunt - The Lancet Respiratory Medicine, 2022 - thelancet.com
… pathophysiological changes associated with thrombosis in COVID-19. We discuss laboratory
findings and clinical consequences of coagulopathy in patients with COVID-19, and outline …

How to recognize and manage COVID-19-associated coagulopathy

GF Gerber, S Chaturvedi - Hematology, 2021 - ashpublications.org
… intensity) on COVID-19 outcomes are eagerly … COVID-19 vaccine-associated cytopenias
and bleeding as well as vaccine-induced thrombotic thrombocytopenia, in which thrombosis

A review of pathophysiology, clinical features, and management options of COVID-19 associated coagulopathy

J Goswami, TA MacArthur, M Sridharan, RK Pruthi… - Shock, 2021 - journals.lww.com
… venous thrombosis associated with COVID-19 infection. … coagulopathy, and current
recommendations for prevention and treatment of thrombotic complications in patients with …

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence

B Ragnoli, B Da Re, A Galantino, S Kette… - International Journal of …, 2023 - mdpi.com
… in developing thrombotic complications during COVID-19 … in COVID-19 complicated by
pulmonary embolism during … in patients with and without pulmonary embolism, suggesting a …

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19

X Wang, KK Sahu, J Cerny - Journal of thrombosis and thrombolysis, 2021 - Springer
… of thrombotic complications in patients with COVID-19-related … to the matched non-COVID-19
ARDS population (11.7% vs. … management of COVID-19-associated coagulopathy (CAC), …

Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy

A Elbeddini, R Gerochi, A Elshahawi - Journal of Pharmaceutical …, 2020 - Taylor & Francis
… One of the most common clinical findings in COVID-19 patients is the occurrence of thrombotic
events despite thromboprophylaxis, leading to poorer outcomes and more ICU transfers. …